Research |
![]() ![]() ![]() ![]() ![]() |
Serial Number | 97938004 |
Mark Drawing Code | 4000: Illustration: Drawing with word(s)/letter(s)/number(s) in Block form |
Attorney Name | Christina M. Licursi |
Attorney Docket Number | F08932000200 |
2023-05-16 | Application Filed |
2023-06-14 | Location: NEW APPLICATION PROCESSING |
2023-06-14 | Status: Live/Pending |
2023-06-21 | Transaction Date |
Owner: | ![]() |
Address | 55 Cambridge Parkway, Suite 800E Cambridge DE 02142 |
Legal Entity Type | Corporation |
Legal Entity State | DE |
Click the blue "Refresh" button to load certificates, specimines, application, and other documents.
International Codes: | 5 |
U.S. Codes: | 005,006,018,044,046,051,052 |
International Codes: | 9 |
U.S. Codes: | 021,023,026,036,038 |
International Codes: | 42 |
U.S. Codes: | 100,101 |
Type Code | Type |
---|---|
GS0051 | Products for the treatment of disease; adjuvants; vaccines; research and development in the field of computational biology, biotechnology and pharmaceuticals; software featuring artificial intelligence, computational methods, and machine learning models for data analysis in the fields of biomedical, and genomic research; software featuring artificial intelligence, computational methods, and machine learning models for the design and characterization of biologic therapeutic products and drug analysis in drug discovery and development; software for the capture, collection, conversion, analysis, communication, processing, receiving, recording, storage and transmission of data, images, information and artificial intelligence in the fields of healthcare, biomedical and genomic research; Scientific research, namely, research and analysis services in the fields of artificial intelligence and machine learning analytics and research relating to drug development |
Description | Date | Event Coding |
---|---|---|
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | 2023-06-21 | 1 NWOS I:Incoming Correspondence |
ASSIGNED TO EXAMINER | 2023-09-22 | 2 DOCK D:Assigned to Examiner |
NON-FINAL ACTION WRITTEN | 2023-09-29 | 3 CNRT R:Renewal |
NON-FINAL ACTION E-MAILED | 2023-09-29 | 4 GNRT F:First Action |
NOTIFICATION OF NON-FINAL ACTION E-MAILED | 2023-09-29 | 5 GNRN O:Outgoing Correspondence |
TEAS RESPONSE TO OFFICE ACTION RECEIVED | 2023-12-07 | 6 TROA I:Incoming Correspondence |
CORRESPONDENCE RECEIVED IN LAW OFFICE | 2023-12-07 | 7 CRFA I:Incoming Correspondence |
TEAS/EMAIL CORRESPONDENCE ENTERED | 2023-12-07 | 8 TEME I:Incoming Correspondence |
SUSPENSION LETTER WRITTEN | 2023-12-13 | 9 CNSL R:Renewal |
LETTER OF SUSPENSION E-MAILED | 2023-12-13 | 10 GNSL S: |
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | 2023-12-13 | 11 GNS3 O:Outgoing Correspondence |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.